+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Banking Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Blood Banking Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Blood Banking Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083942
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Banking Market grew from USD 16.89 billion in 2024 to USD 19.15 billion in 2025. It is expected to continue growing at a CAGR of 13.09%, reaching USD 35.36 billion by 2030.

The blood banking industry stands at a pivotal juncture, driven by rapid technological advancements, evolving regulatory landscapes, and shifting patient needs. In recent years, breakthroughs in component collection techniques and storage methodologies have revolutionized how blood products are processed, preserved, and delivered. Meanwhile, heightened focus on safety has spurred the adoption of pathogen reduction and leukocyte depletion protocols, reinforcing confidence among healthcare providers and recipients alike. Regulatory frameworks are adapting in tandem, emphasizing rigorous quality assurance, supply chain transparency, and compliance with international standards. This confluence of innovation and oversight has created an environment where agility and strategic foresight are critical for stakeholders. As patient populations grow and the demand for specialized therapies expands, blood banks and related organizations must navigate complex market dynamics to optimize resource allocation, ensure inventory resilience, and sustain uninterrupted access. In this executive summary, we examine the transformative forces reshaping blood banking, assess the cumulative impact of recent U.S. tariff changes, distill key segmentation and regional insights, profile leading companies, and offer actionable recommendations. Collectively, these insights aim to equip decision-makers with the intelligence needed to capitalize on emerging opportunities and mitigate potential disruptions.

Transformative Shifts Reshaping the Blood Banking Landscape

Over the past decade, digital innovations and advanced processing techniques have catalyzed profound changes in blood banking. Automated collection systems now coexist with manual methods, enabling operators to tailor donor experiences while maximizing yield. Cryoprecipitate processing-once limited to broad clotting factor applications-has advanced to isolate Factor VIII, Fibrinogen, and Von Willebrand Factor with exceptional purity. Simultaneously, synthetic blood substitutes and human-derived components offer clinicians alternative therapeutic options, reducing reliance on donor availability. Beyond product diversification, end users such as diagnostic laboratories and academic research institutions are leveraging specialized blood products to accelerate translational research. Hospitals-both public and private-have integrated refrigerated, liquid storage, and frozen inventory protocols into their supply chains, enhancing inventory management and reducing wastage. Moreover, the rise of pathogen reduction and irradiative processing methods has elevated transfusion safety, mitigating risks associated with emerging pathogens. These developments, coupled with the expansion of trauma and surgical applications, have collectively repositioned blood banking from a reactive service to a proactive strategic partner in patient care.

Assessing the 2025 U.S. Tariff Impact Across the Value Chain

In early 2025, newly imposed United States tariffs on imported blood collection and processing equipment reshaped cost structures across the value chain. Equipment manufacturers faced elevated duties on automated collection instruments and pathogen reduction technologies, prompting a reassessment of pricing strategies. As a result, procurement departments in hospitals and diagnostic laboratories encountered higher capital expenditures, leading some to extend equipment lifecycles or explore rental models. Meanwhile, suppliers of frozen and refrigerated storage units absorbed a significant portion of the tariff burden to maintain competitive pricing, impacting profit margins. On the regulatory front, U.S. agencies expedited exemption reviews for domestically produced reagents, incentivizing onshore manufacturing of blood substitute products and human-derived components. Transitionary challenges emerged as companies redirected investment toward tariff-compliant facilities and diversified supply sources. Over time, these adjustments are expected to bolster domestic capacity, but the short-term effect includes elevated inventory costs and potential delays in the adoption of next-generation processing platforms. Stakeholders must therefore incorporate revised duty assessments into procurement forecasts and collaborate proactively with manufacturers to navigate the evolving tariff landscape.

Key Insights from Market Segmentation Analysis

A nuanced understanding of market segmentation is essential for strategic positioning. When products are categorized by type-including whole blood, red blood cells, platelet concentrate, plasma, granulocytes, and cryoprecipitate with its specialized factors-decision-makers gain visibility into utilization patterns. For instance, high-purity cryoprecipitate isolates Factor VIII for hemophilia treatment, while broader plasma applications support trauma and surgical interventions. From an end-user perspective, blood banks and diagnostic laboratories focus on high-volume screening and component separation, whereas hospitals-whether private or public-prioritize on-demand transfusion support. Research laboratories, split between academic institutions and private research labs, leverage blood products for oncology protocols such as chemotherapy adjuncts and radiation therapy research. Application segments reveal distinct drivers: anemia management programs rely heavily on red blood cell availability, blood disorders such as sickle cell anemia and thrombocytopenia require targeted platelet therapies, and cancer treatment corridors demand both supportive transfusions and novel synthetic substitutes. Product nature segmentation further distinguishes human-derived offerings from synthetic blood substitutes, each with unique regulatory pathways and cost profiles. Storage conditions-frozen, refrigerated, or liquid-affect shelf life and logistics, while component collection methods, whether manual or automated, influence throughput and donor experience. Finally, donor type segmentation between voluntary and replacement donors shapes recruitment strategies, and processing methods such as leukocyte reduction, irradiative processing, and pathogen reduction underpin safety protocols. Together, these segmentation insights enable stakeholders to tailor product portfolios, optimize distribution networks, and align R&D investments with evolving clinical needs.

Critical Regional Trends Shaping Market Opportunities

Regional dynamics are instrumental in defining strategic priorities. In the Americas, mature infrastructure and established regulatory frameworks facilitate rapid integration of advanced pathogen reduction and leukocyte depletion technologies, yet rising demand in emerging markets underscores the importance of scalable cold-chain solutions. Across Europe, the Middle East, and Africa, heterogeneous regulatory environments present both challenges and opportunities; while Western Europe adopts stringent quality standards, certain regions in the Middle East are investing heavily in synthetic blood research, and African nations are prioritizing safe donor recruitment programs to combat transfusion-transmitted infections. In the Asia-Pacific region, population growth and expanding healthcare access drive demand for both whole blood and specialized components, with countries such as India and China scaling up domestic manufacturing of cryoprecipitate and automated collection systems. Moreover, refrigerated storage innovations are gaining traction in remote geographies to address logistical barriers. Understanding these disparate regional trajectories allows companies to customize market entry strategies, forge targeted partnerships, and allocate resources in high-growth corridors while sustaining service quality in established territories.

Profiles of Leading Companies Driving Innovation

Leading industry participants are charting diverse pathways to capture value and enhance differentiation. Abbott Laboratories continues to refine its point-of-care screening platforms, while AMAG Pharmaceuticals is advancing its human-derived plasma therapeutics portfolio. Americord Registry and ViaCord are expanding cord blood banking services, integrating advanced cryopreservation techniques to improve stem cell viability. Beckman Coulter and Becton, Dickinson and Company are investing in high-throughput automated collection solutions, and Bio-Rad Laboratories along with bioMérieux are strengthening their diagnostic assay pipelines for transfusion-transmitted pathogen detection. Cardinal Health and Johnson & Johnson focus on end-to-end logistics and supply chain partnerships, whereas China Biologic Products and Fresenius Kabi are scaling onshore production capabilities to navigate tariff landscapes. Cordlife Group and Narang Medical are pursuing regional expansion through strategic alliances, while F. Hoffmann-La Roche and Thermo Fisher Scientific lead innovation in synthetic blood substitutes and pathogen reduction reagents. Immucor is enhancing its antibody screening platforms, Krew Instruments is introducing novel donor monitoring devices, Macopharma is optimizing component separation kits, Remi Elektrotechnik is advancing refrigerated storage units, and Terumo BCT is broadening its component collection portfolio. Together, these companies exemplify the multifaceted strategies-from vertical integration to collaborative R&D-that are propelling the sector forward.

Actionable Recommendations for Industry Decision-Makers

To navigate the complexities of the contemporary blood banking landscape, industry leaders should adopt a multifaceted approach. First, forging strategic partnerships between equipment manufacturers and end users will accelerate the deployment of automated collection and pathogen reduction systems, lowering total cost of ownership and enhancing throughput. Second, investing in modular cold-chain and storage innovations-particularly liquid and refrigerated solutions-will mitigate logistical bottlenecks and reduce product wastage. Third, diversifying donor recruitment channels by blending voluntary donor campaigns with targeted replacement donor initiatives can stabilize supply pipelines and improve donor retention. Fourth, fostering in-house reagent development for synthetic blood substitutes and human-derived components will hedge against tariff exposures and supply disruptions. Fifth, aligning R&D efforts with the needs of oncology and trauma care segments-where demand for specialized components like cryoprecipitate factors and granulocyte concentrates is highest-will secure first-mover advantages in emerging therapeutic arenas. Finally, enhancing data analytics capabilities to forecast demand, monitor inventory, and track quality metrics in real time will empower decision-makers to respond swiftly to market fluctuations and regulatory changes.

Conclusion: Navigating the Future of Blood Banking

The blood banking sector stands at the intersection of innovation, regulation, and patient care imperatives. As technological capabilities expand-from advanced leukocyte reduction and pathogen inactivation to high-efficiency automated collection-and as regulatory frameworks evolve, organizations must remain agile and future-focused. Integrating segmentation and regional intelligence enables a more granular allocation of resources, while collaboration across the value chain fosters resilience against supply chain disruptions and tariff pressures. By balancing investment between human-derived and synthetic offerings, and by optimizing storage and distribution networks, stakeholders can deliver safer, more reliable blood products to patients worldwide. The collective adoption of these strategic initiatives will not only strengthen operational excellence but also drive sustainable growth in a market defined by its critical role in healthcare delivery.

Market Segmentation & Coverage

This research report categorizes the Blood Banking Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cryoprecipitate
    • Factor VIII
    • Fibrinogen
    • Von Willebrand Factor
  • Granulocytes
  • Plasma
  • Platelet Concentrate
  • Red Blood Cells
  • Whole Blood
  • Blood Banks
  • Diagnostic Laboratories
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Research Laboratories
    • Academic Institutions
    • Private Research Labs
  • Anemia
  • Blood Disorders
    • Hemophilia
    • Sickle Cell Anemia
    • Thrombocytopenia
  • Cancer Treatment
    • Chemotherapy
    • Radiation Therapy
  • Trauma & Surgeries
  • Blood Substitute Products
  • Human-Derived
  • Synthetic Blood Products
  • Frozen
  • Liquid Storage
  • Refrigerated
  • Automated Collection
  • Manual Collection
  • Replacement Donors
  • Voluntary Donors
  • Irradiative Processing
  • Leukocyte Reduction
  • Pathogen Reduction

This research report categorizes the Blood Banking Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Blood Banking Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • AMAG Pharmaceuticals, Inc.
  • Americord Registry LLC
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • bioMérieux SA
  • Cardinal Health, Inc
  • China Biologic Products, Inc.
  • Cordlife Group Limited
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Immucor, Inc.
  • Johnson & Johnson
  • Krew Instruments Pvt Ltd
  • Macopharma SA
  • Narang Medical Limited
  • Remi Elektrotechnik Limited
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific Inc.
  • ViaCord LLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Banking Market, by Type
8.1. Introduction
8.2. Cryoprecipitate
8.2.1. Factor VIII
8.2.2. Fibrinogen
8.2.3. Von Willebrand Factor
8.3. Granulocytes
8.4. Plasma
8.5. Platelet Concentrate
8.6. Red Blood Cells
8.7. Whole Blood
9. Blood Banking Market, by End-User
9.1. Introduction
9.2. Blood Banks
9.3. Diagnostic Laboratories
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
9.5. Research Laboratories
9.5.1. Academic Institutions
9.5.2. Private Research Labs
10. Blood Banking Market, by Application
10.1. Introduction
10.2. Anemia
10.3. Blood Disorders
10.3.1. Hemophilia
10.3.2. Sickle Cell Anemia
10.3.3. Thrombocytopenia
10.4. Cancer Treatment
10.4.1. Chemotherapy
10.4.2. Radiation Therapy
10.5. Trauma & Surgeries
11. Blood Banking Market, by Product Nature
11.1. Introduction
11.2. Blood Substitute Products
11.3. Human-Derived
11.4. Synthetic Blood Products
12. Blood Banking Market, by Storage
12.1. Introduction
12.2. Frozen
12.3. Liquid Storage
12.4. Refrigerated
13. Blood Banking Market, by Component Collection
13.1. Introduction
13.2. Automated Collection
13.3. Manual Collection
14. Blood Banking Market, by Donor Type
14.1. Introduction
14.2. Replacement Donors
14.3. Voluntary Donors
15. Blood Banking Market, by Processing Method
15.1. Introduction
15.2. Irradiative Processing
15.3. Leukocyte Reduction
15.4. Pathogen Reduction
16. Americas Blood Banking Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Blood Banking Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Blood Banking Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Abbott Laboratories
19.3.2. AMAG Pharmaceuticals, Inc.
19.3.3. Americord Registry LLC
19.3.4. Beckman Coulter, Inc.
19.3.5. Becton, Dickinson and Company
19.3.6. Bio-Rad Laboratories Inc
19.3.7. bioMérieux SA
19.3.8. Cardinal Health, Inc
19.3.9. China Biologic Products, Inc.
19.3.10. Cordlife Group Limited
19.3.11. F. Hoffmann-La Roche Ltd
19.3.12. Fresenius Kabi AG
19.3.13. Immucor, Inc.
19.3.14. Johnson & Johnson
19.3.15. Krew Instruments Pvt Ltd
19.3.16. Macopharma SA
19.3.17. Narang Medical Limited
19.3.18. Remi Elektrotechnik Limited
19.3.19. Terumo BCT, Inc.
19.3.20. Thermo Fisher Scientific Inc.
19.3.21. ViaCord LLC
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BLOOD BANKING MARKET MULTI-CURRENCY
FIGURE 2. BLOOD BANKING MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD BANKING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY STORAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY STORAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD BANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY GRANULOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELET CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD BANKING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD BANKING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD BANKING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD BANKING MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD BANKING MARKET SIZE, BY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD BANKING MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD BANKING MARKET SIZE, BY SICKLE CELL ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD BANKING MARKET SIZE, BY THROMBOCYTOPENIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD BANKING MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD BANKING MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD BANKING MARKET SIZE, BY TRAUMA & SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD SUBSTITUTE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD BANKING MARKET SIZE, BY HUMAN-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD BANKING MARKET SIZE, BY SYNTHETIC BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD BANKING MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD BANKING MARKET SIZE, BY LIQUID STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD BANKING MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD BANKING MARKET SIZE, BY AUTOMATED COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD BANKING MARKET SIZE, BY MANUAL COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD BANKING MARKET SIZE, BY REPLACEMENT DONORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD BANKING MARKET SIZE, BY IRRADIATIVE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD BANKING MARKET SIZE, BY LEUKOCYTE REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD BANKING MARKET SIZE, BY PATHOGEN REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 98. CANADA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. CANADA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 100. CANADA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. CANADA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. CANADA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 103. CANADA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CANADA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 105. CANADA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 107. CANADA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 108. CANADA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 109. CANADA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 165. CHINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. CHINA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 167. CHINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. CHINA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 169. CHINA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 170. CHINA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. CHINA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 172. CHINA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. CHINA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 174. CHINA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 175. CHINA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 176. CHINA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 177. CHINA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 178. INDIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. INDIA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 180. INDIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. INDIA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. INDIA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 183. INDIA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. INDIA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 185. INDIA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. INDIA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 187. INDIA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 188. INDIA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 189. INDIA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 190. INDIA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 204. JAPAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. JAPAN BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 206. JAPAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. JAPAN BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. JAPAN BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 209. JAPAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. JAPAN BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 211. JAPAN BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. JAPAN BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 213. JAPAN BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 214. JAPAN BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 215. JAPAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 216. JAPAN BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 282. THAILAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 283. THAILAND BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 284. THAILAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 285. THAILAND BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. THAILAND BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 287. THAILAND BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. THAILAND BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 290. THAILAND BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 291. THAILAND BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 292. THAILAND BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 293. THAILAND BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 294. THAILAND BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 305. VIETNAM BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 307. VIETNAM BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 322. DENMARK BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 323. DENMARK BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 324. DENMARK BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 325. DENMARK BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 326. DENMARK BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 327. DENMARK BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. DENMARK BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 329. DENMARK BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 330. DENMARK BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 331. DENMARK BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 332. DENMARK BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 333. DENMARK BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 334. DENMARK BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 335. EGYPT BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 336. EGYPT BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 337. EGYPT BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 338. EGYPT BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 339. EGYPT BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 340. EGYPT BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. EGYPT BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 342. EGYPT BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 343. EGYPT BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 344. EGYPT BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 345. EGYPT BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 346. EGYPT BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 347. EGYPT BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 348. FINLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 349. FINLAND BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 350. FINLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 351. FINLAND BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 352. FINLAND BLOOD BANKING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 353. FINLAND BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. FINLAND BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 355. FINLAND BLOOD BANKING MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 356. FINLAND BLOOD BANKING MARKET SIZE, BY PRODUCT NATURE, 2018-2030 (USD MILLION)
TABLE 357. FINLAND BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 358. FINLAND BLOOD BANKING MARKET SIZE, BY COMPONENT COLLECTION, 2018-2030 (USD MILLION)
TABLE 359. FINLAND BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
TABLE 360. FINLAND BLOOD BANKING MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
TABLE 361. FRANCE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 362. FRANCE BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, 2018-2030 (USD MILLION)
TABLE 363. FRANCE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 364. FRANCE BLOOD BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 365.

Companies Mentioned

  • Abbott Laboratories
  • AMAG Pharmaceuticals, Inc.
  • Americord Registry LLC
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • bioMérieux SA
  • Cardinal Health, Inc
  • China Biologic Products, Inc.
  • Cordlife Group Limited
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Immucor, Inc.
  • Johnson & Johnson
  • Krew Instruments Pvt Ltd
  • Macopharma SA
  • Narang Medical Limited
  • Remi Elektrotechnik Limited
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific Inc.
  • ViaCord LLC

Methodology

Loading
LOADING...

Related Topics

Related Reports

Cord Blood Banking Services Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Cord Blood Banking Services Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Cord Blood Banking Services Market Size, Share & Trends Analysis Report By Service (Collection & Transportation, Processing), By Bank (Private, Public, Hybrid), By Component, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Cord Blood Banking Services Market Size, Share & Trends Analysis Report By Service (Collection & Transportation, Processing), By Bank (Private, Public, Hybrid), By Component, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Blood Banking and Blood Products - Global Strategic Business Report - Product Image

Blood Banking and Blood Products - Global Strategic Business Report

  • Report
  • 357 Pages
  • Global
From
Cord Blood Banking Services Market Size, Share, Trends and Forecast by Component, Storage Services, Application, and Region, 2025-2033 - Product Image

Cord Blood Banking Services Market Size, Share, Trends and Forecast by Component, Storage Services, Application, and Region, 2025-2033

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.